Tambagel, Baby Boy B.
HRN: 21-34-94 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/16/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/16/2022
09/23/2022
IV
500 Mg
Q8H
AGE W MOD; T/C Sepsi
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes